Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures

OBJECTIVE: Lusutrombopag is a thrombopoietin receptor agonist that improves thrombocytopenia in patients with chronic liver disease scheduled to undergo invasive procedures. However, information on the efficacy of repeated lusutrombopag treatment and factors associated with the treatment is scarce....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Nishida, Yuno, Kawaoka, Tomokazu, Imamura, Michio, Namba, Maiko, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ohya, Kazuki, Daijo, Kana, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Yamauchi, Masami, Hiramatsu, Akira, Tsuge, Masataka, Aikata, Hiroshi, Takahashi, Shoichi, Hayes, C. Nelson, Fukuhara, Takayuki, Tsuji, Keiji, Arataki, Keiko, Nagaoki, Yuko, Aisaka, Yasuyuki, Kamada, Koji, Kodama, Hideaki, Chayama, Kazuaki
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024946/
https://ncbi.nlm.nih.gov/pubmed/33087674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5930-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados